Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dianthus Therapeutics Inc.

21.87
+1.426.94%
Post-market: 21.870.00000.00%16:30 EDT
Volume:282.09K
Turnover:5.99M
Market Cap:702.58M
PE:-8.57
High:21.96
Open:20.78
Low:20.37
Close:20.45
Loading ...
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 07, 2024

Correspondence

Form CORRESP - Correspondence
Oct 07, 2024

Correspondence

Form CORRESP - Correspondence
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report